To tackle the challenge of implantable device management, GHX worked with providers and suppliers on a solution that would help the industry increase revenue capture and lower supply chain costs. The result is an end-to-end implantable device supply chain (IDSC) solution for both parties designed to help reclaim an estimated $5 billion in annual losses in this market segment. It extends the capabilities of many of our existing, proven solutions, which means current GHX customers are already on the path to IDSC savings.
For providers, the challenge with implantable devices starts before they reach the OR or cath lab. Since implantables are typically on consignment or brought into the hospital from a supplier sales rep’s car, they’re often not on contract and are almost impossible to track. And during surgery, the manual processes for logging and reconciling usage lead to errors, discrepancies and lost revenue.
With the GHX IDSC solution, nurses, materials managers and supplier sales reps can collaborate on case scheduling and prep, leverage automated processes for recording product usage, and send orders and invoices electronically. The GHX IDSC solution automates the majority of steps involved in managing implantables, significantly improving efficiencies and freeing clinicians to stay focused on patients
|Inaccurate catalog & pricing data||7% revenue leakage|
|Complex & manual usage capture||12% invoice discrepencies|
|Multiple usage records||12% overpayments|